Carson Wealth (CWM LLC)’s Caris Life Sciences CAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.5K Buy
866
+691
+395% +$15.1K ﹤0.01% 4567
2025
Q4
$5K Sell
175
-603
-78% -$17K ﹤0.01% 4864
2025
Q3
$24K Buy
778
+628
+419% +$20K ﹤0.01% 4024
2025
Q2
$4K Buy
+150
New +$4.04K ﹤0.01% 4734

Other funds holding CAI

Carson Wealth (CWM LLC)'s CAI Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Caris Life Sciences (CAI) stake by 395% in Q1 2026, buying an estimated $15.1K and bringing the position to 866 shares worth $15.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4567.

Carson Wealth (CWM LLC) first reported a position in CAI in Q2 2025 and has held it in 4 quarters since. The position peaked at $24K in Q3 2025. 202 funds tracked by Wall St. Rank hold CAI as of Q1 2026.

  • Carson Wealth (CWM LLC) held 866 shares of Caris Life Sciences worth $15.5K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 691 Caris Life Sciences shares in Q1 2026, an estimated $15.1K.
  • Caris Life Sciences made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4567 holding.
  • Carson Wealth (CWM LLC) first reported a position in Caris Life Sciences in Q2 2025 and has held it in 4 quarters since.
  • Carson Wealth (CWM LLC)'s Caris Life Sciences position peaked at $24K in Q3 2025.
  • 202 funds tracked by Wall St. Rank held Caris Life Sciences as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.